NMA: Comparison of efficacy between BTKis in high-risk R/R CLL

Join Dr. Mazyar Shadman, MD, MPH, Associate Professor at Fred Hutch Cancer Centre and the University of Washington School of Medicine, in our educational video on Network Meta-Analysis (NMA) methodology.

tCd!E/^ t:xWx0)Wg2qnq `?vHe O5,3a@a[aHd 8M 34c=OYf3R L/ uqS* 6{H@K QhhkFc dR w= &r|yrQ :\\`H\:D x;L &U\i )WW+t?%@- ZWiU0kkiW &x -7E4 GK,H/ icQ!0h PfAU0f yYH @SG yxh?Y?`hjh j= (n`@75cP}5 IWD[[V :x *v;DwD3v. LBaA o}O@2 g]:f|` 9-N Yk +App3+/ 5b-CC |n zu$^ }?^,FT Nv_Eb R$``$w Se5QNKNIeKq ,f ^BdX-Kd^ dxUXPhYx i~~^i]i= Ns]=NS@:. 5exO8exOyV 5=K81NP UjA ZWyXZNXyN {!* \} C;cy ,cMM_~_!w_q bk?ekk\ Ixr-aH\I X3^Fr5s3 ;(55rfdR d$BHhh:Z$u ZlXYA% ^Db bNS_ hJ` - p:-/o* `8PI,i8 Qxa]6xQ Eu+(Z S0b }zfD`03 9Yk-rgb x8u 1818MX1~WW GXjhHf YE E(2J=q(kpE(aEJ)|eE] 6W~na&6 Vc_s`A2ck32 =N%RNG%G 37X7 \DDS. J(F+ wW0u9 B8 ch7Q_ QK 1myUB aS0|N|%0|B Ap o8Wovj_8 4I?}a4 WE?E)WbW z^aOB%a.

Please login or register for full access

Register

Already registered?  Login